# HeartBeam, Inc. (BEATW) — capital_raise/atm_program [expired]
Source: sec.gov · situation sit_6815dd5b2dc6384eadb6 · public 4442818518987477312 · retrieved 2026-08-20T13:20:40.512Z

## Overview
HeartBeam, Inc. is a medical device company that develops and commercializes cardiac diagnostic and monitoring solutions.

HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC on August 14, 2026, pursuant to which the Company may sell up to $25,000,000 of its common stock, par value $0.0001 per share, from time to time through the sales agent. The Shares are issued and sold pursuant to the Company's shelf Registration Statement on Form S-3 (Reg. No. 333-293307). The Company will pay the sales agent a commission of up to 3% of the gross sales price per share for any Shares sold under the Sales Agreement.

## Terms
- Counterparty: Titan Partners Securities LLC · Deal value: $25.0M · Consideration: stock

## Key dates
- Expired 2026-08-14

## Timeline
- 2026-08-14 · 8-K (0001213900-26-090241): 8-K - HeartBeam, Inc. — *HeartBeam, Inc. is a medical device company that develops and commercializes cardiac diagnostic and monitoring solutions.* HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC on August 14, 2026, pursuant to which the Company may sell up to $25,000,000 of its common stock, par value $0.0001 per share, from time to time through the sales agent. The Shares are issued and sold pursuant to the Company's shelf Registration Statement on Form S-3 (Reg. No. 333-293307). The Company will pay the sales agent a commission of up to 3% of the gross sales price per share for any Shares sold under the Sales Agreement.
  https://www.sec.gov/Archives/edgar/data/1779372/0001213900-26-090241.txt

## Citations
- 0001213900-26-090241 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026090241